Home > Boards > US OTC > Delisted > BioPharm Asia, Inc (fka BFAR)

Looks like VFIN is not being quite so

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
hercules16 Member Profile
 
Followed By 0
Posts 88
Boards Moderated 0
Alias Born 09/12/01
160x600 placeholder
FTSE 100 Index Ends the Month 1.76% Lower at 7109.95 -- Data Talk
The FTSE 100 Index is down 127.62 points or 1.76% this month to 7109.95 --Largest one month point and percentage decline since Oct. 2020
DAX Ends the Month 2.60% Lower at 15280.86 -- Data Talk
CAC 40 Index Ends the Month 0.79% Lower at 6776.25 -- Data Talk
STOXX Europe 50 Index Ends the Month 1.70% Lower at 3625.66 -- Data Talk
EURO STOXX 50 Index Ends the Month 3.32% Lower at 4109.51 -- Data Talk
STOXX Europe 600 Index Ends the Month 1.74% Lower at 467.24 -- Data Talk
FTSE 100 Index Ends 0.94% Higher at 7109.95 -- Data Talk
DAX Ends 0.16% Higher at 15280.86 -- Data Talk
CAC 40 Index Ends 0.54% Higher at 6776.25 -- Data Talk
STOXX Europe 50 Index Ends 0.53% Higher at 3625.66 -- Data Talk
EURO STOXX 50 Index Ends 0.49% Higher at 4109.51 -- Data Talk
STOXX Europe 600 Index Ends 0.69% Higher at 467.24 -- Data Talk
FTSE Closes Higher as It Recovers Some Losses From Black Friday
Texas Factory Production Accelerates in November -- Dallas Fed
Avenue Therapeutics Shares Drop 28% After FDA Meeting Scheduled
Fennec Shares Plunge as Pedmark Appears Headed for FDA Rejection
U.S. Pending Home Sales Rose in October, Beating Expectations -- NAR
NRx Pharma Shares Rise 39% After Completing Zyesami Analysis
Top Company News of the Day
Walmart Plans Search for New Finance Chief as Biggs Readies to Leave
Inside the Fed's Powell-Brainard Policy Alliance; Eurozone Inflation Narrative in Spotlight
Celularity Gets FDA Clearance of IND Application for CYNK-101 in Gastric Cancer
Viracta Therapeutics Gets FDA Orphan Drug Designation for Nana-val
German Inflation Rises at Fastest Pace in Almost 30 Years
Swedish Parliament Votes to Re-Elect Magdalena Andersson as PM
Verrica Pharmaceuticals Refiles FDA Application for VP-102
Krystal Biotech Shares More Than Double After Dystrophic EB Trial Meets Objectives
Bristol-Myers Squibb: Deucravacitinib Applications Advance in U.S., Europe
FTSE Rises, BT's Bonds Fall on Takeover Bid Speculation
Immunome Files FDA Application for Covid-19 Antibody Cocktail
Merck, Eisai Get Europe OK for Lenvima/Keytruda Combination in Two Cancers
Fennec Pharmaceuticals Expects FDA to Reject Pedmark Application Again
Reliance Industries Denies BT Group Bid Intent
FTSE Rebounds, Pound Seen as Vulnerable to Omicron Variant
hercules16   Tuesday, 04/17/12 04:27:26 PM
Re: loupai post# 5810
Post # of 7742 
Looks like VFIN is not being quite so obvious in their naked short selling recently. And occasionally the SEC will enforce the rules so it is possible they may continue to be a little more careful in the future.

http://www.sec.gov/news/press/2012/2012-66.htm

Didn't see where there any significant penalty imposed (they had to agree to stop violating the law - wow!). So if VFIN has knowledge that BFAR is a scam who can blame them for blatantly ignoring the law.



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences